Will allogeneic CAR T cells for CD19+ malignancies take autologous CAR T cells 'off the shelf'?

Will allogeneic CAR T cells for CD19⁺ malignancies take autologous CAR T cells 'off the shelf'?

Nat Rev Clin Oncol. 2021 Apr;18(4):195-196. doi: 10.1038/s41571-021-00485-1.

Amanda M DiNofia^{1

2}, Stephan A Grupp^{3

4}

¹ Cancer Immunotherapy Program, Cellular Therapy and Transplant Section, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
² Division of Oncology, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
³ Cancer Immunotherapy Program, Cellular Therapy and Transplant Section, Children's Hospital of Philadelphia, Philadelphia, PA, USA. grupp@chop.edu.
⁴ Division of Oncology, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. grupp@chop.edu.

No abstract available